KeyCorp Reaffirms Buy Rating for Teladoc, Inc. (TDOC)

KeyCorp restated their buy rating on shares of Teladoc, Inc. (NYSE:TDOC) in a research report report published on Sunday. They currently have a $37.00 target price on the health services provider’s stock.

A number of other equities research analysts also recently commented on the company. TheStreet downgraded Teladoc from a c- rating to a d rating in a report on Monday, July 3rd. Zacks Investment Research downgraded Teladoc from a hold rating to a sell rating in a report on Monday, July 17th. Cantor Fitzgerald reiterated a hold rating on shares of Teladoc in a report on Monday, August 28th. Piper Jaffray Companies reiterated a buy rating and issued a $32.00 price objective on shares of Teladoc in a report on Friday, July 14th. Finally, William Blair reiterated an outperform rating on shares of Teladoc in a report on Tuesday, June 20th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of Buy and a consensus target price of $35.82.

Teladoc (TDOC) opened at 30.90 on Friday. The company’s 50-day moving average price is $34.32 and its 200-day moving average price is $34.32. The firm’s market capitalization is $1.75 billion. Teladoc has a 12-month low of $14.00 and a 12-month high of $37.55.

Teladoc (NYSE:TDOC) last released its quarterly earnings data on Wednesday, August 2nd. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). The company had revenue of $44.60 million during the quarter, compared to the consensus estimate of $44.39 million. Teladoc had a negative net margin of 47.75% and a negative return on equity of 19.88%. The company’s revenue for the quarter was up 68.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.38) EPS. Equities analysts expect that Teladoc will post ($1.44) EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “KeyCorp Reaffirms Buy Rating for Teladoc, Inc. (TDOC)” was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://www.chaffeybreeze.com/2017/09/21/keycorp-reaffirms-buy-rating-for-teladoc-inc-tdoc.html.

In other Teladoc news, insider Adam C. Vandervoort sold 53,806 shares of the stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $30.92, for a total value of $1,663,681.52. Following the completion of the sale, the insider now directly owns 33,008 shares in the company, valued at $1,020,607.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 4.47% of the stock is owned by corporate insiders.

Several institutional investors have recently made changes to their positions in the business. FMR LLC increased its holdings in shares of Teladoc by 1.3% in the second quarter. FMR LLC now owns 8,209,737 shares of the health services provider’s stock worth $284,879,000 after acquiring an additional 106,500 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Teladoc by 38.9% in the first quarter. Wellington Management Group LLP now owns 4,228,082 shares of the health services provider’s stock worth $105,701,000 after acquiring an additional 1,183,435 shares in the last quarter. BlackRock Inc. increased its holdings in shares of Teladoc by 42.9% in the second quarter. BlackRock Inc. now owns 3,844,402 shares of the health services provider’s stock worth $133,400,000 after acquiring an additional 1,154,852 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Teladoc by 11.5% in the second quarter. Vanguard Group Inc. now owns 3,041,725 shares of the health services provider’s stock worth $105,547,000 after acquiring an additional 314,646 shares in the last quarter. Finally, Alliancebernstein L.P. increased its holdings in shares of Teladoc by 22.2% in the second quarter. Alliancebernstein L.P. now owns 2,793,590 shares of the health services provider’s stock worth $96,938,000 after acquiring an additional 507,390 shares in the last quarter.

About Teladoc

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Analyst Recommendations for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply